Banque Cantonale Vaudoise’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-1,042
| Closed | -$23K | – | 1056 |
|
2023
Q4 | $23K | Sell |
1,042
-247
| -19% | -$5.45K | ﹤0.01% | 879 |
|
2023
Q3 | $27K | Sell |
1,289
-33
| -2% | -$691 | ﹤0.01% | 1030 |
|
2023
Q2 | $62K | Hold |
1,322
| – | – | ﹤0.01% | 941 |
|
2023
Q1 | $55K | Hold |
1,322
| – | – | ﹤0.01% | 940 |
|
2022
Q4 | $50K | Hold |
1,322
| – | – | ﹤0.01% | 951 |
|
2022
Q3 | $52K | Sell |
1,322
-27
| -2% | -$1.06K | ﹤0.01% | 978 |
|
2022
Q2 | $44K | Sell |
1,349
-720
| -35% | -$23.5K | ﹤0.01% | 1018 |
|
2022
Q1 | $68K | Sell |
2,069
-2,439
| -54% | -$80.2K | ﹤0.01% | 971 |
|
2021
Q4 | $192K | Sell |
4,508
-275
| -6% | -$11.7K | 0.01% | 836 |
|
2021
Q3 | $212K | Buy |
4,783
+272
| +6% | +$12.1K | 0.01% | 782 |
|
2021
Q2 | $256K | Buy |
4,511
+429
| +11% | +$24.3K | 0.01% | 782 |
|
2021
Q1 | $306K | Sell |
4,082
-81
| -2% | -$6.07K | 0.02% | 667 |
|
2020
Q4 | $360K | Sell |
4,163
-3,591
| -46% | -$311K | 0.02% | 577 |
|
2020
Q3 | $474K | Buy |
7,754
+450
| +6% | +$27.5K | 0.03% | 443 |
|
2020
Q2 | $304K | Sell |
7,304
-137
| -2% | -$5.7K | 0.02% | 539 |
|
2020
Q1 | $214K | Buy |
7,441
+4,618
| +164% | +$133K | 0.02% | 604 |
|
2019
Q4 | $204K | Buy |
+2,823
| New | +$204K | 0.01% | 718 |
|